Percutan bal pitvari fülcsezárás dabigatrannal való fülcsethrombus feloldását követoen

Zsuzsanna Kis, Csaba Földesi, Mátyás Pál, Zoltán Som, Andrea Csillik, Pál Ábrahám, András Temesvári, Géza Fontos, A. Szatmári, P. Andréka, A. Kardos

Research output: Article

1 Citation (Scopus)

Abstract

The "gold standard" of the prevention of atrial fibrillation related thromboembolic events is anticoagulation therapy with oral vitamin K antagonists. A certain proportion of high-risk patients with atrial fibrillation are not receiving effective antithrombotic therapy because of problems associated with its use. Resolution of subsequent left atrial appendage thrombi is quite a great challenge in patients who are not tolerating "standard" antithrombotic drugs. According to the knowledge of the authors, this is the first report of a patient with non-valvular persistent atrial fibrillation and high stroke risk, who was intolerant to "standard" anticoagulant therapy and had persistent left atrial appendage thrombi following the use of a wide variety of "standard" anticoagulants. Successful resolution of left atrial appendage thrombi with dabigatran and successful percutaneous left atrial appendage closure were performed in this case. Orv. Hetil., 2013, 154, 262-265.

Original languageHungarian
Pages (from-to)262-265
Number of pages4
JournalOrvosi Hetilap
Volume154
Issue number7
DOIs
Publication statusPublished - 2013

Fingerprint

Atrial Appendage
Thrombosis
Atrial Fibrillation
Anticoagulants
Vitamin K
Therapeutics
Stroke
Dabigatran
Pharmaceutical Preparations

Keywords

  • atrial fibrillation
  • dabigatran
  • left atrial appendage thrombi
  • percutaneous left atrial appendage closure

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Percutan bal pitvari fülcsezárás dabigatrannal való fülcsethrombus feloldását követoen. / Kis, Zsuzsanna; Földesi, Csaba; Pál, Mátyás; Som, Zoltán; Csillik, Andrea; Ábrahám, Pál; Temesvári, András; Fontos, Géza; Szatmári, A.; Andréka, P.; Kardos, A.

In: Orvosi Hetilap, Vol. 154, No. 7, 2013, p. 262-265.

Research output: Article

Kis, Z, Földesi, C, Pál, M, Som, Z, Csillik, A, Ábrahám, P, Temesvári, A, Fontos, G, Szatmári, A, Andréka, P & Kardos, A 2013, 'Percutan bal pitvari fülcsezárás dabigatrannal való fülcsethrombus feloldását követoen', Orvosi Hetilap, vol. 154, no. 7, pp. 262-265. https://doi.org/10.1556/OH.2013.29550
Kis, Zsuzsanna ; Földesi, Csaba ; Pál, Mátyás ; Som, Zoltán ; Csillik, Andrea ; Ábrahám, Pál ; Temesvári, András ; Fontos, Géza ; Szatmári, A. ; Andréka, P. ; Kardos, A. / Percutan bal pitvari fülcsezárás dabigatrannal való fülcsethrombus feloldását követoen. In: Orvosi Hetilap. 2013 ; Vol. 154, No. 7. pp. 262-265.
@article{2ff4de1954bb47d4ae76c7d2052881fa,
title = "Percutan bal pitvari f{\"u}lcsez{\'a}r{\'a}s dabigatrannal val{\'o} f{\"u}lcsethrombus felold{\'a}s{\'a}t k{\"o}vetoen",
abstract = "The {"}gold standard{"} of the prevention of atrial fibrillation related thromboembolic events is anticoagulation therapy with oral vitamin K antagonists. A certain proportion of high-risk patients with atrial fibrillation are not receiving effective antithrombotic therapy because of problems associated with its use. Resolution of subsequent left atrial appendage thrombi is quite a great challenge in patients who are not tolerating {"}standard{"} antithrombotic drugs. According to the knowledge of the authors, this is the first report of a patient with non-valvular persistent atrial fibrillation and high stroke risk, who was intolerant to {"}standard{"} anticoagulant therapy and had persistent left atrial appendage thrombi following the use of a wide variety of {"}standard{"} anticoagulants. Successful resolution of left atrial appendage thrombi with dabigatran and successful percutaneous left atrial appendage closure were performed in this case. Orv. Hetil., 2013, 154, 262-265.",
keywords = "atrial fibrillation, dabigatran, left atrial appendage thrombi, percutaneous left atrial appendage closure",
author = "Zsuzsanna Kis and Csaba F{\"o}ldesi and M{\'a}ty{\'a}s P{\'a}l and Zolt{\'a}n Som and Andrea Csillik and P{\'a}l {\'A}brah{\'a}m and Andr{\'a}s Temesv{\'a}ri and G{\'e}za Fontos and A. Szatm{\'a}ri and P. Andr{\'e}ka and A. Kardos",
year = "2013",
doi = "10.1556/OH.2013.29550",
language = "Hungarian",
volume = "154",
pages = "262--265",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "7",

}

TY - JOUR

T1 - Percutan bal pitvari fülcsezárás dabigatrannal való fülcsethrombus feloldását követoen

AU - Kis, Zsuzsanna

AU - Földesi, Csaba

AU - Pál, Mátyás

AU - Som, Zoltán

AU - Csillik, Andrea

AU - Ábrahám, Pál

AU - Temesvári, András

AU - Fontos, Géza

AU - Szatmári, A.

AU - Andréka, P.

AU - Kardos, A.

PY - 2013

Y1 - 2013

N2 - The "gold standard" of the prevention of atrial fibrillation related thromboembolic events is anticoagulation therapy with oral vitamin K antagonists. A certain proportion of high-risk patients with atrial fibrillation are not receiving effective antithrombotic therapy because of problems associated with its use. Resolution of subsequent left atrial appendage thrombi is quite a great challenge in patients who are not tolerating "standard" antithrombotic drugs. According to the knowledge of the authors, this is the first report of a patient with non-valvular persistent atrial fibrillation and high stroke risk, who was intolerant to "standard" anticoagulant therapy and had persistent left atrial appendage thrombi following the use of a wide variety of "standard" anticoagulants. Successful resolution of left atrial appendage thrombi with dabigatran and successful percutaneous left atrial appendage closure were performed in this case. Orv. Hetil., 2013, 154, 262-265.

AB - The "gold standard" of the prevention of atrial fibrillation related thromboembolic events is anticoagulation therapy with oral vitamin K antagonists. A certain proportion of high-risk patients with atrial fibrillation are not receiving effective antithrombotic therapy because of problems associated with its use. Resolution of subsequent left atrial appendage thrombi is quite a great challenge in patients who are not tolerating "standard" antithrombotic drugs. According to the knowledge of the authors, this is the first report of a patient with non-valvular persistent atrial fibrillation and high stroke risk, who was intolerant to "standard" anticoagulant therapy and had persistent left atrial appendage thrombi following the use of a wide variety of "standard" anticoagulants. Successful resolution of left atrial appendage thrombi with dabigatran and successful percutaneous left atrial appendage closure were performed in this case. Orv. Hetil., 2013, 154, 262-265.

KW - atrial fibrillation

KW - dabigatran

KW - left atrial appendage thrombi

KW - percutaneous left atrial appendage closure

UR - http://www.scopus.com/inward/record.url?scp=84873640685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873640685&partnerID=8YFLogxK

U2 - 10.1556/OH.2013.29550

DO - 10.1556/OH.2013.29550

M3 - Article

C2 - 23395790

AN - SCOPUS:84873640685

VL - 154

SP - 262

EP - 265

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 7

ER -